Copyright Reports & Markets. All rights reserved.

Global Kinase Inhibitors Market Research Report 2019

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Kinase Inhibitors Industry
  • 1.7 COVID-19 Impact: Kinase Inhibitors Market Trends

    • 2 Global Kinase Inhibitors Quarterly Market Size Analysis

    • 2.1 Kinase Inhibitors Business Impact Assessment - COVID-19
      • 2.1.1 Global Kinase Inhibitors Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Kinase Inhibitors Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Kinase Inhibitors Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Kinase Inhibitors Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Kinase Inhibitors Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Kinase Inhibitors Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Kinase Inhibitors Market
    • 3.5 Key Manufacturers Kinase Inhibitors Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Kinase Inhibitors Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Tyrosin kinase inhibitors (TKI)
      • 1.4.2 Receptor Tyrosine Kinase Inhibitors
      • 1.4.3 Non-Receptor Tyrosine Kinase Inhibitors
      • 1.4.4 Mulikinase inhibitors
      • 1.4.5 Threonine kinase inhibitor
      • 1.4.6 Others
    • 4.2 By Type, Global Kinase Inhibitors Market Size, 2019-2021
      • 4.2.1 By Type, Global Kinase Inhibitors Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Kinase Inhibitors Price, 2020-2021

    5 Impact of Covid-19 on Kinase Inhibitors Segments, By Application

    • 5.1 Overview
      • 5.5.1 Pharmaceutical companies
      • 5.5.2 Private and Government research institutes
      • 5.5.3 Academic Institutes
      • 5.5.4 Healthcare facilities
    • 5.2 By Application, Global Kinase Inhibitors Market Size, 2019-2021
      • 5.2.1 By Application, Global Kinase Inhibitors Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Kinase Inhibitors Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Bristol-Myers Squibb
      • 7.1.1 Bristol-Myers Squibb Business Overview
      • 7.1.2 Bristol-Myers Squibb Kinase Inhibitors Quarterly Production and Revenue, 2020
      • 7.1.3 Bristol-Myers Squibb Kinase Inhibitors Product Introduction
      • 7.1.4 Bristol-Myers Squibb Response to COVID-19 and Related Developments
    • 7.2 Boehringer Ingelheim
      • 7.2.1 Boehringer Ingelheim Business Overview
      • 7.2.2 Boehringer Ingelheim Kinase Inhibitors Quarterly Production and Revenue, 2020
      • 7.2.3 Boehringer Ingelheim Kinase Inhibitors Product Introduction
      • 7.2.4 Boehringer Ingelheim Response to COVID-19 and Related Developments
    • 7.3 Cytrx Corporation
      • 7.3.1 Cytrx Corporation Business Overview
      • 7.3.2 Cytrx Corporation Kinase Inhibitors Quarterly Production and Revenue, 2020
      • 7.3.3 Cytrx Corporation Kinase Inhibitors Product Introduction
      • 7.3.4 Cytrx Corporation Response to COVID-19 and Related Developments
    • 7.4 Eisai Inc.
      • 7.4.1 Eisai Inc. Business Overview
      • 7.4.2 Eisai Inc. Kinase Inhibitors Quarterly Production and Revenue, 2020
      • 7.4.3 Eisai Inc. Kinase Inhibitors Product Introduction
      • 7.4.4 Eisai Inc. Response to COVID-19 and Related Developments
    • 7.5 Eton Bioscience Inc.
      • 7.5.1 Eton Bioscience Inc. Business Overview
      • 7.5.2 Eton Bioscience Inc. Kinase Inhibitors Quarterly Production and Revenue, 2020
      • 7.5.3 Eton Bioscience Inc. Kinase Inhibitors Product Introduction
      • 7.5.4 Eton Bioscience Inc. Response to COVID-19 and Related Developments
    • 7.6 Glaxosmithkline
      • 7.6.1 Glaxosmithkline Business Overview
      • 7.6.2 Glaxosmithkline Kinase Inhibitors Quarterly Production and Revenue, 2020
      • 7.6.3 Glaxosmithkline Kinase Inhibitors Product Introduction
      • 7.6.4 Glaxosmithkline Response to COVID-19 and Related Developments
    • 7.7 Merck Serono Sa
      • 7.7.1 Merck Serono Sa Business Overview
      • 7.7.2 Merck Serono Sa Kinase Inhibitors Quarterly Production and Revenue, 2020
      • 7.7.3 Merck Serono Sa Kinase Inhibitors Product Introduction
      • 7.7.4 Merck Serono Sa Response to COVID-19 and Related Developments
    • 7.8 Novartis International Ag
      • 7.8.1 Novartis International Ag Business Overview
      • 7.8.2 Novartis International Ag Kinase Inhibitors Quarterly Production and Revenue, 2020
      • 7.8.3 Novartis International Ag Kinase Inhibitors Product Introduction
      • 7.8.4 Novartis International Ag Response to COVID-19 and Related Developments
    • 7.9 Osi Pharmaceuticals Llc
      • 7.9.1 Osi Pharmaceuticals Llc Business Overview
      • 7.9.2 Osi Pharmaceuticals Llc Kinase Inhibitors Quarterly Production and Revenue, 2020
      • 7.9.3 Osi Pharmaceuticals Llc Kinase Inhibitors Product Introduction
      • 7.9.4 Osi Pharmaceuticals Llc Response to COVID-19 and Related Developments
    • 7.10 Pfizer
      • 7.10.1 Pfizer Business Overview
      • 7.10.2 Pfizer Kinase Inhibitors Quarterly Production and Revenue, 2020
      • 7.10.3 Pfizer Kinase Inhibitors Product Introduction
      • 7.10.4 Pfizer Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Kinase Inhibitors Supply Chain Analysis
      • 8.1.1 Kinase Inhibitors Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Kinase Inhibitors Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Kinase Inhibitors Distribution Channels
      • 8.2.2 Covid-19 Impact on Kinase Inhibitors Distribution Channels
      • 8.2.3 Kinase Inhibitors Distributors
    • 8.3 Kinase Inhibitors Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Kinase Inhibitors, including the following market information:
      Global Kinase Inhibitors Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Kinase Inhibitors Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Kinase Inhibitors Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Kinase Inhibitors Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Bristol-Myers Squibb, Boehringer Ingelheim, Cytrx Corporation, Eisai Inc., Eton Bioscience Inc., Glaxosmithkline, Merck Serono Sa, Novartis International Ag, Osi Pharmaceuticals Llc, Pfizer, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Tyrosin kinase inhibitors (TKI)
      Receptor Tyrosine Kinase Inhibitors
      Non-Receptor Tyrosine Kinase Inhibitors
      Mulikinase inhibitors
      Threonine kinase inhibitor
      Others

      Based on the Application:
      Pharmaceutical companies
      Private and Government research institutes
      Academic Institutes
      Healthcare facilities

      Buy now